Navigation Links
Faster Approval Procedures Urged For New TB Drugs

Medicins Sans Frontiers(MSF), on Monday called for fast tracking of the approval procedures for drugs which are likely to be effective against extremely drug resistant// tuberculosis(XDR-TB) which is highly prevalent, especially in sub Saharan Africa.

MSF otherwise called Doctors Without Borders(DWB) has urged that the regulatory bodies like the US Food and Drug Administraton(USFDA) and European Medicines Agency step up their pace in developing the promising drugs and make them available.

It was thought earlier that TB had been contained and its eradication was only a matter of time. But the respiratory disease is now back in the form of a new virulent drug resistant strain. The World Health Organization(WHO) estimates that nearly 2 million people worldwide die of TB each year, 99% of them from developing countries.

People with HIV/AIDS are likelier to be susceptible to it because of their low immunity levels and one third of them are infected with TB.

Around 450,000 people are infected yearly with strains that resist treatment with first-line antibiotics, and an increasing number are also untreatable with second-line drugs, "making treatment with existing drugs virtually impossible," MSF said.

The head of Doctors Without Borders, Rowan Gillies, said that research into TB drugs has not been a priority for the past 40-50 years, and that the WHO should take the initiative to deal with this crisis immediately.

The first of the drugs in the pipeline is not going to be ready before 2010 at the current speed of operations, and others will be even more delayed.

Three other medicines are now in clinical trials -- Johnson & Johnson's Diarylquinoline, Otsuka's Nitroimidazo, and Pyrrole by Lupin Ltd and Tido von Schoen-Angerer, director of MSF's Campaign for Access to Essential Medicines, said that it is important that they be brought to the market quickly.

He said fast-tracki ng the three drugs could help curb the spreading of the difficult strains and urged the WHO to ensure adequate funding into TB research. He suggested that just as the first HIV drugs were made available even before final approval, the new TB drugs be given to the needy patients as soon as they were proven safe.
MAL
'"/>




Related medicine news :

1. Faster way of producing Bird flu vaccine using Reverse Genetics
2. Wounds Heal 25% Faster In Older Adults Who Exercise Regularly
3. Singapore’s Healthcare To Outsource To Indian Firm For Faster X-Ray Result
4. New Antibiotic For Faster Relief From Asthma
5. Adolescent Girls Have Faster Psychological Improvement Than Boys
6. A New break Through In Surgery May Help In Faster Recovery Of Patients
7. Bubble-Blowing Infants may Learn Language Skills Faster
8. Arrested Drug Offenders Offered Faster Help
9. Honey Works Faster than Antibiotics in Healing Wounds
10. New Research Suggests That Obesity Strikes Faster Growing Kids
11. Drug Prices Rising Faster Than Inflation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... ... December 06, 2016 , ... It can be argued that people these days ... members as they do for their human friends and family. As pets have ... highest quality and most innovative pet products has also increased. , For ...
(Date:12/6/2016)... ... December 06, 2016 , ... The Behavioral Health Center ... recognizing the organization as a top behavioral service provider in the country. The ... quality, staff satisfaction and qualifications, and consumer satisfaction. These areas are measured via ...
(Date:12/6/2016)... ... December 06, 2016 , ... Gateway Analytical, one of ... particle counting and sizing services for USP 788 and 789 particulate standards compliance. ... as a response to the needs of pharmaceutical and medical device manufacturers, who ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has a ... world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every day ...
(Date:12/6/2016)... Vancouver, B.C., Canada (PRWEB) , ... December 06, ... ... Consultants (STC) announce the availability of the newly updated International Audit Protocol Consortium ... world use IAPC EHS audit protocols to understand the scope of their EHS ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... N.J. , Dec. 5, 2016  Daiichi ... preliminary safety and efficacy data from a phase ... MDM2 inhibitor, suggesting that DS-3032 may be a ... myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). ... the phase 1 study of DS-3032 were presented in ...
(Date:12/5/2016)... -- BD (Becton, Dickinson and Company) (NYSE: BDX ... an enhanced technology platform designed with the ability to ... Pyxis™ and Alaris™ systems, at this year,s American ... being held in Las Vegas ... that approximately 68 percent of medication errors occur during ...
(Date:12/5/2016)... , Dec. 5, 2016 Eisai Inc. ... at the 2016 Annual Meeting of the American Epilepsy ... CIII, is indicated as an adjunctive therapy for the ... secondarily generalized seizures and primary generalized tonic-clonic seizures (PGTC) ... age and older. Please see Important Safety Information for ...
Breaking Medicine Technology: